244 related articles for article (PubMed ID: 23673334)
21. Lack of effect of stimulant combination with second-generation antipsychotics on weight gain, metabolic changes, prolactin levels, and sedation in youth with clinically relevant aggression or oppositionality.
Penzner JB; Dudas M; Saito E; Olshanskiy V; Parikh UH; Kapoor S; Chekuri R; Gadaleta D; Avedon J; Sheridan EM; Randell J; Malhotra AK; Kane JM; Correll CU
J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):563-73. PubMed ID: 19877981
[TBL] [Abstract][Full Text] [Related]
22. Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000.
Ganguly R; Kotzan JA; Miller LS; Kennedy K; Martin BC
J Clin Psychiatry; 2004 Oct; 65(10):1377-88. PubMed ID: 15491242
[TBL] [Abstract][Full Text] [Related]
23. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 2: antipsychotics and traditional mood stabilizers.
Pringsheim T; Hirsch L; Gardner D; Gorman DA
Can J Psychiatry; 2015 Feb; 60(2):52-61. PubMed ID: 25886656
[TBL] [Abstract][Full Text] [Related]
24. Maintenance phase treatment of psychotic disorders in outpatients from Serbia - focus on long-term benzodiazepine use.
Marić NP; Andrić Petrović S; Jerotić S; Ristić I; Savić B; Zebić M; Vuković V; Britvić D; Golubović O; Jakšić M; Jevđić K; Kolašinac Z; Lalović N; Mirković Ilić J; Nikolić S; Paunović Č; Pavlović Z; Pejović Nikolić S; Perović V; Popović J; Ranđić Avakumović V; Stojanović S; Tatarević M; Živković I; Voskresenski T; Jovanović N
Int J Psychiatry Clin Pract; 2020 Sep; 24(3):315-321. PubMed ID: 32459564
[No Abstract] [Full Text] [Related]
25. Frequency and Correlates of Acute Dystonic Reactions After Antipsychotic Initiation in 441 Children and Adolescents.
Tural Hesapcioglu S; Ceylan MF; Kandemir G; Kasak M; Sen CP; Correll CU
J Child Adolesc Psychopharmacol; 2020 Jul; 30(6):366-375. PubMed ID: 32255662
[No Abstract] [Full Text] [Related]
26. Trends in Antipsychotic Prescribing in Medicaid-Eligible Youth.
Edelsohn GA; Karpov I; Parthasarathy M; Hutchison SL; Castelnovo K; Ghuman J; Schuster JM
J Am Acad Child Adolesc Psychiatry; 2017 Jan; 56(1):59-66. PubMed ID: 27993230
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and nature of antipsychotic polypharmacy among inpatients with schizophrenia spectrum disorders at an Australian mental health service.
John AP; Gee T; Alexander S; Ramankutty P; Dragovic M
Australas Psychiatry; 2014 Dec; 22(6):546-50. PubMed ID: 25147317
[TBL] [Abstract][Full Text] [Related]
28. Access to Psychosocial Services Prior to Starting Antipsychotic Treatment Among Medicaid-Insured Youth.
Finnerty M; Neese-Todd S; Pritam R; Leckman-Westin E; Bilder S; Byron SC; Hudson Scholle S; Crystal S; Olfson M
J Am Acad Child Adolesc Psychiatry; 2016 Jan; 55(1):69-76.e3. PubMed ID: 26703912
[TBL] [Abstract][Full Text] [Related]
29. Antipsychotic polypharmacy and augmentation strategies prior to clozapine initiation: a historical cohort study of 310 adults with treatment-resistant schizophrenic disorders.
Thompson JV; Clark JM; Legge SE; Kadra G; Downs J; Walters JT; Hamshere ML; Hayes RD; Taylor D; MacCabe JH
J Psychopharmacol; 2016 May; 30(5):436-43. PubMed ID: 26905920
[TBL] [Abstract][Full Text] [Related]
30. Antipsychotic polypharmacy: a Japanese survey of prescribers' attitudes and rationales.
Kishimoto T; Watanabe K; Uchida H; Mimura M; Kane JM; Correll CU
Psychiatry Res; 2013 Oct; 209(3):406-11. PubMed ID: 23602697
[TBL] [Abstract][Full Text] [Related]
31. Antipsychotic polypharmacy: a survey study of prescriber attitudes, knowledge and behavior.
Correll CU; Shaikh L; Gallego JA; Nachbar J; Olshanskiy V; Kishimoto T; Kane JM
Schizophr Res; 2011 Sep; 131(1-3):58-62. PubMed ID: 21419603
[TBL] [Abstract][Full Text] [Related]
32. Ten years of antipsychotic prescribing to children: a Canadian population-based study.
Alessi-Severini S; Biscontri RG; Collins DM; Sareen J; Enns MW
Can J Psychiatry; 2012 Jan; 57(1):52-8. PubMed ID: 22296959
[TBL] [Abstract][Full Text] [Related]
33. Antipsychotic polypharmacy and quality of life in patients with schizophrenia treated in primary care in China.
Hou CL; Ma XR; Zang Y; Jia FJ; Lin YQ; Chiu HF; Ungvari GS; Ng CH; Zhong BL; Cao XL; Li Y; Cai MY; Xiang YT
Int J Clin Pharmacol Ther; 2016 Jan; 54(1):36-42. PubMed ID: 26521927
[TBL] [Abstract][Full Text] [Related]
34. Antipsychotic prescription and polypharmacy among outpatients with schizophrenia in a Nigerian hospital.
Anozie IG; James BO; Omoaregba JO
Niger Postgrad Med J; 2020; 27(1):30-36. PubMed ID: 32003359
[TBL] [Abstract][Full Text] [Related]
35. Switching to antipsychotic monotherapy vs. staying on antipsychotic polypharmacy in schizophrenia: A systematic review and meta-analysis.
Matsui K; Tokumasu T; Takekita Y; Inada K; Kanazawa T; Kishimoto T; Takasu S; Tani H; Tarutani S; Hashimoto N; Yamada H; Yamanouchi Y; Takeuchi H
Schizophr Res; 2019 Jul; 209():50-57. PubMed ID: 31182319
[TBL] [Abstract][Full Text] [Related]
36. Combination pharmacotherapy for psychiatric disorders in children and adolescents: prevalence, efficacy, risks and research needs.
Jureidini J; Tonkin A; Jureidini E
Paediatr Drugs; 2013 Oct; 15(5):377-91. PubMed ID: 23757196
[TBL] [Abstract][Full Text] [Related]
37. Antipsychotic polypharmacy among elderly patients with schizophrenia and dementia during hospitalization at a Taiwanese psychiatric hospital.
Wu YH; Lai CY; Chang YS
Psychogeriatrics; 2015 Mar; 15(1):7-13. PubMed ID: 25515355
[TBL] [Abstract][Full Text] [Related]
38. Prescribing trends and indications of antipsychotic medication in Hong Kong from 2004 to 2014: General and vulnerable patient groups.
Lao KSJ; Tam AWY; Wong ICK; Besag FMC; Man KKC; Chui CSL; Chan EW
Pharmacoepidemiol Drug Saf; 2017 Nov; 26(11):1387-1394. PubMed ID: 28665012
[TBL] [Abstract][Full Text] [Related]
39. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs.
Olfson M; Blanco C; Liu L; Moreno C; Laje G
Arch Gen Psychiatry; 2006 Jun; 63(6):679-85. PubMed ID: 16754841
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons.
Fraguas D; Correll CU; Merchán-Naranjo J; Rapado-Castro M; Parellada M; Moreno C; Arango C
Eur Neuropsychopharmacol; 2011 Aug; 21(8):621-45. PubMed ID: 20702068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
